Nanocarry Therapeutics Overview
Nanocarry is developing therapeutics based on bioengineered nanoparticles with novel capabilities to treat oncology indications and brain diseases. The company’s AxS platform can be easily modified to deliver a wide array of biologics, safely and effectively, to the brain and beyond. Nanocarry’s first products in development are for brain metastases of HER2+ breast cancer and non-small cell lung cancer.
Cumulative Funding Raised Over Time ($)
Latest News
No news articles.
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | $1M |
| Last funding | Undisclosed |
| Stage | Pre-Seed |
| Rounds | 4 |
| Investors | 3 |
Team Members
3
Employees: 11-50
Web & Social Links
| Website | nanocarry.com/ |
Locations
Pinhas Sapir Street 3, Ness Ziona, Israel
Photos & Videos
No files yet
Nanocarry Therapeutics Business
Sector
Health Tech & Life SciencesDigital HealthcareDigital TherapeuticsPharma & Medical BiotechnologyDrugs Discovery & DevelopmentTarget Customer
Healthcare & Life SciencesLife SciencesBiotechnologyPharmaceuticalsCore Technology
BiologicalsCellsTags (4)
personalized-treatmentmedical-technologiescancertreatmentsNanocarry Therapeutics Financials
Cumulative Funding Raised Over Time ($)
Private Equity Funding
Non-Equity Funding
Nanocarry Therapeutics Lifecycle
Cumulative Funding Raised Over Time
All Events
Nanocarry Therapeutics News
0 articlesNo news articles.
Nanocarry Therapeutics Team
Employee Info
| Employees (range) | 11-50 |
| Exact count | 11 |
| Team members | 3 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
This entity has 10 classification IDs that could be used for matching.
Nanocarry Therapeutics Internal
Recent Updates
No update log entries.
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 88/100 |
| Missing | video or image, news, markets, not claimed |
| BI Verification | Yanina Wainscheinker |
| Registrar ID | 516332640 |
| Crunchbase | nanocarry-therapeutics |
| Creator | Matan Eblagon |
| Creator email | matane@sncentral.org |
| Last updater | Matan Eblagon |
| Updater email | matane@sncentral.org |
| Last update | 2024-08-11T00:00:00.000Z |
| Created | 2022-08-08T00:00:00.000Z |